Genmab A/S (GMAB) Earnings Date, Estimates & Call Transcripts

$26.20

-0.23 (-0.87%)

(As of 09/18/2024 ET)

Upcoming Earnings Date: Nov. 6
After Market Closes
Confirmed
Actual EPS (Aug. 8): $0.22 Missed By -$0.07
Consensus EPS (Aug. 8): $0.29

GMAB Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

GMAB Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Golden Crest

Biden's Successor: The Radical Threat to YOUR Savings!

Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.

>> Get Your FREE Wealth Protection Guide <<

Genmab A/S Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate	Company Guidance
Q1 2024	3	$0.14	$0.26	$0.18
Q2 2024	3	$0.26	$0.34	$0.30
Q3 2024	3	$0.27	$0.35	$0.30
Q4 2024	3	$0.27	$0.41	$0.32
FY 2024	12	$0.94	$1.36		$1.10

GMAB Earnings Date and Information

Genmab A/S last posted its quarterly earnings data on August 8th, 2024. The reported $0.22 EPS for the quarter, missing the consensus estimate of $0.29 by $0.07. The company had revenue of $779.50 million for the quarter, compared to analysts' expectations of $734.60 million. Genmab A/S has generated $1.20 earnings per share over the last year ($1.20 diluted earnings per share) and currently has a price-to-earnings ratio of 21.8. Earnings for Genmab A/S are expected to grow by 18.11% in the coming year, from $1.27 to $1.50 per share. Genmab A/S has confirmed that its next quarterly earnings report will be published on Wednesday, November 6th, 2024.

Genmab A/S Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/6/2024 (Confirmed)	-	-	-	-	-	-	-
8/8/2024	Q2 2024	$0.29	$0.22	($0.07)	$0.13	$734.60 million	$779.50 million
5/2/2024	Q1 2024	$0.16	$0.16	-	$0.03	$594.23 million	$603.30 million
2/14/2024	Q4 2023	$0.34	$0.36	+$0.02	$0.58	$678.14 million	$675.29 million
11/7/2023	Q3 2023	$0.34	$0.47	+$0.13	$0.47	$657.79 million	$692.80 million
8/3/2023	Q2 2023	$0.31	$0.30	($0.01)	$0.30	$618.77 million	$613.43 million
5/10/2023	Q1 2023	$0.09	$0.05	($0.04)	$0.05	$417.27 million	$411.37 million
Get the Latest News and Ratings for GMAB and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Genmab A/S and its competitors with MarketBeat's FREE daily newsletter.
2/22/2023	Q4 2022	$0.35	$0.12	($0.23)	$0.12	$634.17 million	$717.54 million
11/9/2022	Q3 2022	$0.23	$0.53	+$0.30	$0.53	$486.10 million	$553.71 million
8/10/2022	Q2 2022	$0.21	$0.41	+$0.20	$0.41	$435.40 million	$452.86 million
5/11/2022	Q1 2022	$0.10	$0.11	+$0.01	$0.11	$304.16 million	$319.54 million
2/16/2022	Q4 2021	$0.13	$0.17	+$0.04	$0.17	$387.16 million	$402.74 million
11/10/2021	Q3 2021	$0.11	$0.21	+$0.10	$0.21	$341.46 million	$366.25 million
8/11/2021	Q2 2021	$0.08	$0.08	-	$0.08	$268.28 million	$319.48 million
5/5/2021	Q1 2021	$0.05	$0.27	+$0.22	$0.27	$214.90 million	$256.24 million
2/22/2021	Q4 2020	$0.12	$0.14	+$0.02	$0.14	$288.86 million	$327.51 million
11/4/2020	Q3 2020	$0.10	$0.13	+$0.03	$0.13	$232.86 million	$273.43 million
8/12/2020	Q2 2020	$0.88	$0.76	($0.12)	$0.76	$828.85 million	$804.62 million
5/6/2020	Q1 2020	$0.02	$0.06	+$0.04	$0.06	$133.04 million	$131.69 million
2/19/2020	Q4 2019	$0.36	$0.34	($0.02)	$0.34	$406.46 million	$438.89 million
11/6/2019	Q3 2019	$0.08	$1.26	+$1.18	$1.26	$139.37 million	$158.22 million

Genmab A/S Earnings - Frequently Asked Questions

When is Genmab A/S's earnings date?: Genmab A/S has confirmed that its next quarterly earnings data will be published on Wednesday, November 6th, 2024. Learn more on GMAB's earnings history.
What guidance has Genmab A/S issued on next quarter's earnings?: Genmab A/S issued an update on its FY 2024 earnings guidance on Thursday, August, 8th. The company issued revenue guidance of $3.0 billion-$3.1 billion, compared to the consensus revenue estimate of $2.9 billion.
Did Genmab A/S beat their earnings estimates last quarter?: In the previous quarter, Genmab A/S (NASDAQ:GMAB) missed the analysts' consensus estimate of $0.29 by $0.07 with a reported earnings per share (EPS) of $0.22. Learn more on analysts' earnings estimate vs. GMAB's actual earnings.
How much revenue does Genmab A/S generate each year?: Genmab A/S (NASDAQ:GMAB) has a recorded annual revenue of $19.02 billion.
How much profit does Genmab A/S generate each year?: Genmab A/S (NASDAQ:GMAB) has a recorded net income of $631.91 million. GMAB has generated $1.20 earnings per share over the last four quarters.
What is Genmab A/S's price-to-earnings ratio?: Genmab A/S (NASDAQ:GMAB) has a trailing price-to-earnings ratio of 21.83 and a forward price-to-earnings ratio of 20.63. The price/earnings-to-growth ratio is 0.81.
What is Genmab A/S's EPS forecast for next year?: Genmab A/S's earnings are expected to grow from $1.27 per share to $1.50 per share in the next year, which is a 18.11% increase.